Found 292 matching trials
Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy PHASE2 Radiotherapy can activate local and systemic immune responses through a var...
Show More Location
Multiple Locations
Learn More & Join Trial
Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer PHASE2 This prospective real-world study aims to evaluate the effectiveness and sa...
Show More Location
Air Force Military Medical University
Learn More & Join Trial
RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer PHASE2 This study is a prospective, open-label, phase II clinical trial that aims ...
Show More Location
Multiple Locations
Learn More & Join Trial
Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer PHASE3 This is a randomized, controlled, multicenter clinical study that enrolled ...
Show More Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer PHASE1 This study will investigate the safety and effectiveness of a new combinati...
Show More Learn More & Join Trial
Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma PHASE2 This study aims to systematically evaluate the safety and efficacy of adali...
Show More Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Learn More & Join Trial
A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy PHASE2 This study aims to evaluate the efficacy and safety of adebrelimab consolid...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma PHASE2 To evaluate the initial efficacy and safety of paclitaxel for injection (al...
Show More Location
The First Affiliated Hospital of Xiamen University
Learn More & Join Trial
Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer PHASE2 Our study is aimed to evaluate the efficacy and safety of novel ADC named S...
Show More Location
Fudan Cancer Hospital
Learn More & Join Trial
Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy PHASE2 Patients with locally advanced unresectable or metastatic hepatocellular ca...
Show More Location
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Learn More & Join Trial